1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Issue 10374 (4th February 2023) Authors: Swen, Jesse J; van der Wouden, Cathelijne H; Manson, Lisanne EN; Abdullah-Koolmees, Heshu; Blagec, Kathrin; Blagus, Tanja; Böhringer, Stefan; Cambon-Thomsen, Anne; Cecchin, Erika; Cheung, Ka-Chun; Deneer, Vera HM; Dupui, Mathilde; Ingelman-Sundberg, Magnus; Jonsson, Siv; Joefield-Roka, Candace; J... Journal: Lancet Issue: Volume 401:Issue 10374(2023) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 401:Issue 10387(2023) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10285 (1st May 2021) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdul-Rahee... Journal: Lancet Issue: Volume 397:Issue 10285(2021) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗